Lymphocyte Activation Gene-3 Antagonists [MoA] - N0000194002

Name: Table of NDC products with lymphocyte activation gene-3 antagonists
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000194002
Pharmacologic Name	Lymphocyte Activation Gene-3 Antagonists
Pharmacologic Uses	lymphocyte activation gene-3 (LAG-3) blocking antibody
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Lymphocyte Activation Gene-3 Antagonists

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Lymphocyte Activation Gene-3 Antagonists [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0003-7125	Opdualag	Non-Proprietary Name: Nivolumab And Relatlimab-rmbw	Injection	Intravenous	E.r. Squibb & Sons, L.l.c.	ACTIVE